WALTHAM, Mass., Nov. 6, 2008 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (NasdaqGM:OXGN - News) (Stockholm:OXGN.ST - News), a clinical stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that CEO John Kollins will present a corporate overview and update at the Rodman and Renshaw 10th Annual Healthcare Conference on Monday, November 10th, at 4:05 p.m. EST (1:05 p.m. PST), in the Palace Hotel in New York City, N.Y.
